Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2000
09/08/2000CA2363139A1 Methods and reagents for inhibiting angiogenesis
09/08/2000CA2362995A1 Anti-neoplastic compositions and uses thereof
09/08/2000CA2362924A1 Secreted proteins and nucleic acids encoding them
09/08/2000CA2362911A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors
09/08/2000CA2362826A1 Formation and anion-exchange of crystalline echinocandin ammonium salts
09/08/2000CA2362825A1 Cdna for human methylenetetrahydrofolate reductase
09/08/2000CA2362817A1 Novel cyclic tetrapeptide derivatives and pharmaceutical use thereof
09/08/2000CA2362547A1 Angiopoietin-related protein and nucleic acids
09/08/2000CA2362501A1 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists
09/08/2000CA2362498A1 Mucin containing ophthalmic preparations
09/08/2000CA2362482A1 Processes for making pharmaceutical oral ecb formulations and compositions
09/08/2000CA2362477A1 Anti-plasmodium compositions and methods of use
09/08/2000CA2362016A1 Echinocandin/carbohydrate complexes
09/08/2000CA2361877A1 Antibodies for cancer therapy and diagnosis
09/08/2000CA2327260A1 Methods of modulating lipid metabolism and storage
09/07/2000DE19910394A1 Substanzen für die Fertilitätskontrolle Substances for fertility control
09/07/2000DE19909503A1 Tumorassoziiertes Antigen Tumor-associated antigen
09/07/2000DE19909357A1 Kupferagonist, der an die Kupferbindungsstelle von APP bindet und/oder eine hemmende Wirkung auf die Freisetzung des Amyloid-Aß-Peptids ausübt Kupferagonist which binds to the copper binding site of APP and / or exerts an inhibitory effect on the release of the amyloid Aß-peptide
09/06/2000EP1033574A2 Morphogenic protein screening method
09/06/2000EP1033403A1 Gene originating in human fetal chondrocytes
09/06/2000EP1033373A1 Feline granulocyte colony-stimulating factor
09/06/2000EP1033372A1 Compounds with antitumor activity
09/06/2000EP1033135A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens
09/06/2000EP1033134A1 Compositions inhibiting smooth muscle proliferation, method for the diagnosis of arteriosclerosis, and kits therefor
09/06/2000EP1033128A2 Soft gelatin capsule manufacture
09/06/2000EP1032838A1 125 human secreted proteins
09/06/2000EP1032708A1 Nucleic acid ligands of tissue target
09/06/2000EP1032706A1 Reagents and methods useful for detecting diseases of the breast
09/06/2000EP1032696A1 Vector for tissue-specific replication and gene expression
09/06/2000EP1032689A1 Reagents and methods useful for detecting diseases of the breast
09/06/2000EP1032688A1 Single-chain bifunctional glycoprotein hormones
09/06/2000EP1032682A1 Desaturase genes and their use
09/06/2000EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION
09/06/2000EP1032675A1 Attaching substances to micro-organisms
09/06/2000EP1032672A1 Dna19355 polypeptide, a tumor necrosis factor homolog
09/06/2000EP1032671A1 Mammalian cytokine-like polypeptide-10
09/06/2000EP1032670A1 Toso
09/06/2000EP1032669A2 Recombinant allergen with reduced enzymatic activity
09/06/2000EP1032667A2 A33-related antigens and their pharmacological uses
09/06/2000EP1032666A1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
09/06/2000EP1032664A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
09/06/2000EP1032662A1 Methods and compositions for immunomodulation
09/06/2000EP1032661A1 Apo-2DcR
09/06/2000EP1032660A1 Method of identifying binding site domains that retain the capacity of binding to an epitop
09/06/2000EP1032656A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
09/06/2000EP1032652A1 Secreted proteins and polynucleotides encoding them
09/06/2000EP1032651A1 INDUCIBLE CELLULAR IMMUNITY THROUGH ACTIVATION OF Th1 AND SUPPRESSION OF Th2 RESPONSES BY MACROPHAGES
09/06/2000EP1032650A1 Novel tig
09/06/2000EP1032649A1 deoD
09/06/2000EP1032596A1 Lactalbumin production process
09/06/2000EP1032595A2 Nucleic acids involved in the responder phenotype and applications thereof
09/06/2000EP1032594A1 Secreted proteins and polynucleotides encoding them
09/06/2000EP1032593A1 Secreted proteins and polynucleotides encoding them
09/06/2000EP1032592A1 Antimicrobial peptides
09/06/2000EP1032591A1 NOVEL pth
09/06/2000EP1032589A1 Secreted proteins and polynucleotides encoding them
09/06/2000EP1032588A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors
09/06/2000EP1032587A1 Novel exendin agonist compounds
09/06/2000EP1032582A1 NOVEL recJ
09/06/2000EP1032562A2 Advanced glycation end-product intermediaries and post-amadori inhibition
09/06/2000EP1032428A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
09/06/2000EP1032427A2 Conjugates of cytokines and drugs or genes for treating proliferating cells
09/06/2000EP1032426A1 Therapeutic agents
09/06/2000EP1032421A1 Monoclonal human natural antibodies
09/06/2000EP1032420A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
09/06/2000EP1032415A2 Composition for the treatment of allergic conditions having cysteine and serine proteinase inhibitory activity
09/06/2000EP1032414A1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
09/06/2000EP1032413A1 Chemoprotective bacterial strains
09/06/2000EP1032412A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells
09/06/2000EP1032409A1 Herbal extract composition and method with immune-boosting capability
09/06/2000EP1032397A1 Testosterone inhibitors and use for the protection of neurons
09/06/2000EP1032382A1 Anti-obesity agent
09/06/2000EP1032373A1 Drug delivery systems utilizing liquid crystal structures
09/06/2000EP1032371A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
09/06/2000EP1032370A1 Porous hydroxyapatite particles as carriers for drug substances
09/06/2000EP1032269A1 Treatment of neoplasms with viruses
09/06/2000EP0901379B1 Type-2 chemokine binding proteins and methods of use therefor
09/06/2000EP0882066B1 Peptide derivatives
09/06/2000EP0785947B1 Peptides endowed with antiinflammatory activity
09/06/2000EP0770089B1 Growth differentiation factor-12
09/06/2000EP0631502B1 Lymphocyte activity regulation by hla peptides
09/06/2000EP0590015B1 Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer
09/06/2000EP0587858B1 Protein formulation comprising growth hormone
09/06/2000EP0504388B1 Varicella-zoster virus antigen
09/06/2000CN1265701A Cleaning articles comprising cellulosic fibrous structure having discrete low basis weight regions and inverse emulsion
09/06/2000CN1265675A Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265674A 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265673A Dipeptide compounds which inhibit leukocyte adhesion medicated by VLA-4
09/06/2000CN1265672A Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265671A Alatrofloxacin parenteral compositions
09/06/2000CN1265670A Dipeptide and related compounds which inhibit leukocyte adhesion medicated by VLA-4
09/06/2000CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265668A Subtsituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265648A Conjugaes of dithiocarbamates with pharmacologically active agents and uses therefor
09/06/2000CN1265600A Cloning pigs using donor nuclei from differentiated cells
09/06/2000CN1265599A Cloning using donor nuclei from non-serum starved, differentiated cells
09/06/2000CN1265598A Method for treating thrombotic disorders
09/06/2000CN1265583A Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols
09/06/2000CN1265560A Composition and method for curing diabetes
1 ... 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 ... 3163